Recombinant Rickettsia felis Octanoyltransferase (lipB)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order remarks to ensure fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
lipB; RF_1383; Octanoyltransferase; EC 2.3.1.181; Lipoate-protein ligase B; Lipoyl/octanoyl transferase; Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-209
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) (Rickettsia azadi)
Target Names
lipB
Target Protein Sequence
MLQFITIPNL MDYRVTLKLM EDYVNKVISD NEPEIVYLVE HSEVYTAGTN YKQEELLNYG DIPVIYTGRG GKFTFHGPGQ RVIYPILNLA SPNRHKDLKL YIKMLEEWII NSLNYFGIKT YIIKDKVGIW VKVRKGEFAK IAAIGVRVRK WVTYHGVAIN ISTDLSKFSG IIPCGLENSL VTSLNQLGIH IEMSEFDKII QTEFNKIFK
Uniprot No.

Target Background

Function

This enzyme catalyzes the transfer of endogenously produced octanoic acid from octanoyl-acyl-carrier-protein to the lipoyl domains of lipoate-dependent enzymes. While lipoyl-ACP can also serve as a substrate, octanoyl-ACP is more likely the physiological substrate.

Database Links

KEGG: rfe:RF_1383

STRING: 315456.RF_1383

Protein Families
LipB family
Subcellular Location
Cytoplasm.

Q&A

What is the genomic context of lipB in Rickettsia felis and how does it compare to other rickettsial species?

Rickettsia felis lipB is part of the lipolytic enzyme family that plays important roles in bacterial metabolism. Based on genome-wide analysis, R. felis contains several conserved lipolytic enzymes with the lipB gene encoding a protein with dual functionality. In the R. felis genome, lipB belongs to the family VIII carboxylesterases, characterized by specific conserved motifs including S-x-x-K (positions 118-121), Y-x-x (239-241), and W-x-G (407-409) . These motifs are critical for the protein's catalytic activity.

When comparing across rickettsial species, the genomic organization around lipB shows considerable conservation, though R. felis exhibits some unique characteristics that distinguish it from related species like R. typhi and other spotted fever group rickettsiae. This conservation pattern suggests functional importance throughout the evolution of these intracellular pathogens .

What are the structural characteristics of Rickettsia felis lipB protein?

The R. felis lipB protein consists of 454 amino acid residues with a predicted molecular weight of 48.4 kDa. Structural analysis reveals that lipB is composed of two distinct domains:

  • A small helical domain (residues 136-257) consisting of four alpha-helices and a short two-stranded antiparallel beta-sheet

  • An alpha/beta-domain (residues 1-135 and 258-454) containing five long antiparallel beta-sheets, two pairs of short two-stranded antiparallel beta-sheet, and 10 alpha-helices

These domains together form a catalytic active pocket where the three conserved motifs (S-x-x-K, Y-x-x, W-x-G) precisely fit. The key catalytic residues (Ser118, Lys121, and Tyr239) are positioned within this pocket to facilitate enzyme activity .

3D structure modeling indicates similarities with other class C β-lactamases and family VIII carboxylesterases, supporting its predicted dual functionality. The structural arrangement is optimized for interactions with both short-chain fatty acid esters and β-lactam compounds .

What are the optimal conditions for heterologous expression of soluble Rickettsia felis lipB?

Expression of soluble recombinant R. felis lipB presents significant challenges, consistent with many rickettsial proteins. Based on experimental data from similar enzymes, the following approach is recommended:

Optimal Expression System:

  • Host: E. coli BL21(DE3)

  • Vector: pET-29b with MBP (maltose-binding protein) fusion tag

  • IPTG concentration: 0.1 mM

  • Temperature: 16°C

  • Induction time: 22 hours

Direct expression with histidine tags (His-LipB) typically results in insoluble protein aggregates even after optimization of induction conditions. The MBP fusion dramatically improves solubility, though attempts to cleave the MBP tag post-purification often result in protein precipitation .

Table 1: Comparison of Expression Conditions for R. felis lipB

ParameterHis-Tag ApproachMBP-Tag Approach
VectorpET28apET-29b
Temperature16-37°C16°C
IPTG concentration0.1-1.0 mM0.1 mM
Duration6-22 h22 h
SolubilityInsolubleSoluble
Tag removalN/AResults in precipitation

What purification strategy yields highest purity and activity for recombinant R. felis lipB?

For optimal purification of MBP-lipB fusion protein, a multi-step approach is recommended:

  • Initial Capture: Amylose affinity chromatography

    • Equilibration buffer: 20 mM Tris-HCl pH 7.5, 200 mM NaCl

    • Wash buffer: Same as equilibration buffer

    • Elution buffer: Equilibration buffer supplemented with 10 mM maltose

  • Polishing Step: Gel permeation chromatography

    • Buffer: 50 mM phosphate buffer pH 7.0, 150 mM NaCl

    • Column recommendation: Superdex 200 Increase 10/300 GL

The purified MBP-lipB fusion protein should be used directly for activity assays without attempting tag removal. Storage at -80°C in 20% glycerol maintains activity for up to 6 months. Buffer exchange into activity-specific buffers should be performed immediately before assays to prevent destabilization .

How can the dual functionality of R. felis lipB be comprehensively assessed?

R. felis lipB exhibits both esterase and β-lactamase activities, requiring different methodological approaches for comprehensive characterization:

For Esterase Activity:

  • Plate-based screening: Use tributyrin agar plates (1% tributyrin) to visualize clear zones around colonies expressing active enzyme.

  • Spectrophotometric assay: Employ p-nitrophenyl esters of varying chain lengths (C2-C12) with detection at 405 nm.

    • Standard conditions: 50 mM phosphate buffer (pH 7.0), 30°C

    • Substrate range: 0.1-1.0 mM

    • Reaction time: Monitor continuously for 10 minutes

For β-lactamase Activity:

  • Nitrocefin assay: Rapid colorimetric detection at 486 nm

    • Buffer: 50 mM phosphate buffer (pH 7.0)

    • Substrate concentration: 100 μM nitrocefin

    • Temperature: 30°C

  • HPLC-based activity assay:

    • Substrates: ampicillin, cefotaxime, imipenem

    • Detection parameters:

      • Ampicillin: 230 nm, flow rate 0.5 mL/min

      • Cefotaxime: 254 nm, flow rate 0.8 mL/min

      • Imipenem: 295 nm, flow rate 1.0 mL/min

What kinetic parameters should be determined for comprehensive characterization of R. felis lipB?

For thorough enzymatic characterization, the following kinetic parameters should be determined for both activities:

Table 2: Essential Kinetic Parameters for R. felis lipB Characterization

ParameterEsterase Activityβ-lactamase Activity
KmFor C2-C12 substratesFor various β-lactams
kcatAt optimal conditionsAt optimal conditions
kcat/KmCatalytic efficiencyCatalytic efficiency
pH optimumpH range 3.0-10.0pH range 3.0-7.5*
Temperature optimum20-60°C20-50°C*
Inhibition profilesWith various inhibitorsWith β-lactamase inhibitors

*Note: β-lactamase substrate (nitrocefin) is unstable under thermal (≥55°C) or alkaline (pH ≥8.0) conditions .

Determination of these parameters requires steady-state kinetics using varied substrate concentrations. For temperature and pH optima, standardized buffer systems should be used to minimize variability (acetate buffer for pH 4.0-5.5, phosphate buffer for pH 6.0-8.0, and Tris-HCl for pH 8.5-9.0).

How can site-directed mutagenesis be used to investigate the catalytic mechanism of R. felis lipB?

Based on structural analysis and sequence alignments, targeted mutagenesis of the conserved motifs can provide insights into the catalytic mechanism:

Priority Mutation Targets:

  • S-x-x-K motif: Ser118 and Lys121 are critical for catalysis

    • S118A: Expected to abolish both esterase and β-lactamase activities

    • K121A/R: Will help determine the role in substrate positioning versus direct catalysis

  • Y-x-x motif: Tyr239 likely participates in the catalytic mechanism

    • Y239F: Conservative substitution to test hydroxyl group importance

    • Y239A: More drastic change to assess structural requirements

  • W-x-G motif: Residues (Trp407, Gly409) contribute to the oxyanion hole

    • W407A: Would likely disrupt substrate binding pocket

    • G409A: Could affect structural flexibility

Experimental Verification:

  • Express each variant under identical conditions as wild-type

  • Assess structural integrity via circular dichroism (CD) spectroscopy

  • Compare kinetic parameters for both activities to determine specific effects of mutations

  • Use molecular dynamics simulations to support experimental findings

What approaches can be used to investigate potential inhibitors of R. felis lipB?

Understanding inhibition patterns of R. felis lipB would provide insights into both its biochemical properties and potential antimicrobial development strategies:

Inhibitor Screening Approaches:

  • Targeted screening:

    • β-lactamase inhibitors (clavulanic acid, sulbactam, tazobactam)

    • Esterase inhibitors (PMSF, E-64, pepstatin A)

    • Metal ions (Ca²⁺, Mg²⁺, Zn²⁺, Cu²⁺, Fe²⁺)

    • Organic solvents effects (methanol, ethanol, isopropanol, DMSO)

  • High-throughput screening:

    • Modified nitrocefin assay in 384-well format

    • Fluorescent substrate-based assays for enhanced sensitivity

Inhibition Kinetics:

  • Determine inhibition constants (Ki) and inhibition types

  • For time-dependent inhibitors, evaluate kinact and Ki values

  • Use enzyme-inhibitor structures to guide development of specific inhibitors

Inhibitor studies can provide valuable insights into structural differences between R. felis lipB and homologous enzymes from other organisms, potentially revealing species-specific targeting opportunities .

How might R. felis lipB contribute to pathogenesis in flea and mammalian hosts?

R. felis lipB potentially plays multiple roles in pathogenesis across different hosts:

In Flea Vectors:

  • May contribute to utilization of lipid resources within the flea gut

  • Could influence R. felis colonization dynamics, as suggested by varying infection loads observed in cat fleas (Ctenocephalides felis)

  • Might play a role in R. felis persistence during transovarial transmission, which is critical for maintaining the pathogen in flea populations

In Mammalian Hosts:

  • β-lactamase activity could contribute to antimicrobial resistance

  • Lipolytic activity might assist in membrane interactions or lipid acquisition

  • May participate in evasion of host immune responses

The enzyme's dual functionality suggests adaptability to different host environments, potentially explaining the pathogen's ability to persist in both arthropod vectors and mammalian hosts. Further animal model studies are needed to clarify the exact contribution to virulence .

How does expression of recombinant R. felis lipB contribute to development of diagnostic tools?

Recombinant R. felis lipB has potential applications in developing improved diagnostic approaches:

Serological Diagnostics:

  • Purified recombinant lipB could serve as a specific antigen in ELISA-based serological tests

  • Development of antibodies against unique epitopes of lipB might improve differentiation between R. felis and closely related species like R. typhi

PCR-Based Diagnostics:

  • Understanding lipB sequence variations can inform development of species-specific PCR primers

  • RFLP analysis targeting lipB regions could complement existing methods for differentiating R. felis from R. felis-like organisms

Improved diagnostics are particularly important given the emerging global threat status of R. felis infections, which are often misdiagnosed due to symptom overlap with other febrile illnesses like dengue fever and murine typhus .

How does R. felis lipB compare structurally and functionally with homologous enzymes in other Rickettsia species?

Comparative analysis reveals important evolutionary insights about R. felis lipB:

Structural Comparison:

  • R. felis lipB shares core structural elements with homologs across the Rickettsia genus

  • Key differences in substrate-binding regions may explain species-specific activity profiles

  • The dual functionality appears variably conserved across species, suggesting evolutionary adaptations

Functional Divergence:

  • Enzymatic efficiency varies among rickettsial species, potentially correlating with host preference and transmission patterns

  • R. felis lipB shows higher sequence similarity to spotted fever group rickettsiae than to typhus group, despite R. felis having a flea vector similar to R. typhi

Table 3: Comparison of Key Features Between R. felis lipB and Homologs

FeatureR. felis lipBR. typhi homologOther SFG Rickettsia homologs
Size454 aa, 48.4 kDaSmaller (estimated 42 kDa)Variable (45-50 kDa)
Catalytic triadSer118, Lys121, Tyr239Conserved positionsConserved positions
β-lactamase activityPresentWeakerVariable
Esterase substrate preferenceShort-chain (C4)Shorter (C2-C3)Variable
Host adaptation signaturesFlea-optimizedFlea-optimizedTick-optimized in SFG rickettsiae

This comparison highlights how R. felis occupies a unique evolutionary position between spotted fever and typhus groups, possibly explaining its success in establishing infections in diverse arthropod vectors .

What coinfection scenarios involving R. felis might impact lipB expression and function?

Coinfection dynamics can significantly influence gene expression and protein function in rickettsial species:

R. felis and R. typhi Coinfections:

  • Studies have demonstrated that cat fleas can simultaneously harbor both R. felis and R. typhi

  • During coinfection, R. felis growth is often reduced compared to single infections

  • These altered growth dynamics could impact lipB expression levels and activity profiles

Expression Regulation:

  • Transcriptional profiling indicates potential upregulation of metabolic enzymes like lipB during competitive coinfection scenarios

  • Changes in gene expression may represent adaptive responses to resource competition

  • The presence of R. typhi may trigger stress responses in R. felis that alter lipB regulation

Functional Implications:

  • Altered lipB activity during coinfection might influence transmission efficiency

  • Changes in enzyme functionality could contribute to pathogen persistence in coinfected fleas

  • Competition for resources may drive selection for enhanced enzymatic efficiency

Understanding these dynamics is crucial for developing targeted interventions, as coinfections may enhance transmission potential of either agent .

What are the common challenges in obtaining active recombinant R. felis lipB and how can they be addressed?

Researchers frequently encounter several challenges when working with recombinant R. felis lipB:

Problem 1: Protein Insolubility

  • Observation: Direct expression with His-tag results in insoluble protein

  • Solution:

    • Use MBP fusion tag with N-terminal positioning

    • Express at reduced temperature (16°C) with low IPTG concentration (0.1 mM)

    • Include 5% glycerol in lysis buffer to enhance stability

    • Consider SUMO or thioredoxin tags as alternatives if MBP is unsuitable

Problem 2: Low Activity in Recombinant Preparations

  • Observation: Purified enzyme shows significantly lower activity than predicted

  • Solutions:

    • Verify proper folding using circular dichroism or limited proteolysis

    • Include metallic cofactors (Zn²⁺, Ca²⁺) in activity buffer

    • Optimize buffer conditions (pH 6.5-7.5) and include reducing agents

    • Test activity immediately after purification to avoid freeze-thaw cycles

Problem 3: Inconsistent Results Between Assays

  • Observation: Variations in measured activity across different experimental setups

  • Solutions:

    • Standardize protein quantification methods

    • Establish positive controls with known activity

    • Use internal standards for each experiment

    • Account for background activity from E. coli proteins in preparations

How can researchers optimize transcriptional analysis of R. felis lipB gene expression in infected fleas?

Analyzing lipB gene expression in the natural vector context presents unique challenges:

RNA Extraction Optimization:

  • Use specialized extraction protocols designed for arthropod samples containing bacteria

  • Include mechanical disruption step optimized for flea tissues

  • Process samples rapidly to minimize RNA degradation

  • Consider carrier RNA addition for low-abundance samples

RT-qPCR Strategy:

  • Design primers spanning exon-exon junctions to discriminate transcripts from genomic DNA

  • Use multiple reference genes (both host and bacterial) for reliable normalization

  • Include no-RT controls to detect genomic DNA contamination

  • Develop standard curves using recombinant plasmids containing target sequences

Data Interpretation:

  • Express results as relative copy numbers normalized to flea 18S rDNA and R. felis 17-kDa reference genes

  • Calculate infection density as the ratio of logarithmically transformed target gene copies

  • Apply appropriate statistical analyses (ANOVA) to examine differences across sampling timepoints

  • Consider both prevalence and infection load to fully understand dynamics

This approach has successfully detected transcripts of R. felis genes in infected fleas, including full-length transcripts of genes containing stop codons, and can be applied to study lipB expression .

What emerging technologies could advance our understanding of R. felis lipB structure-function relationships?

Several cutting-edge approaches could significantly enhance our understanding of R. felis lipB:

Cryo-Electron Microscopy:

  • Determine high-resolution structures without crystallization challenges

  • Visualize enzyme-substrate complexes in various conformational states

  • Map structural dynamics during catalysis

AlphaFold2 and Machine Learning Approaches:

  • Generate highly accurate structure predictions to guide experimental design

  • Model interactions with potential substrates and inhibitors

  • Predict effects of mutations on protein stability and function

Time-Resolved X-ray Solutions Scattering:

  • Capture conformational changes during catalysis

  • Identify transient intermediates in the reaction mechanism

  • Correlate structural dynamics with kinetic measurements

Single-Molecule Förster Resonance Energy Transfer (smFRET):

  • Monitor real-time conformational changes during substrate binding and catalysis

  • Detect heterogeneity in enzyme populations

  • Characterize dynamics of domain movements during different catalytic functions

How might a deeper understanding of R. felis lipB contribute to novel control strategies for flea-borne rickettsioses?

Research on R. felis lipB has significant implications for developing new approaches to control flea-borne rickettsioses:

Target-Based Drug Development:

  • Structure-guided design of specific inhibitors targeting unique features of lipB

  • Development of lipB-targeting prodrugs activated in rickettsial infections

  • Combination approaches targeting multiple rickettsial enzymes simultaneously

Vector-Based Interventions:

  • Creation of transgenic fleas with modified lipB recognition systems

  • Development of transmission-blocking vaccines targeting lipB epitopes

  • Design of small molecules that interfere with lipB function in the flea environment

Diagnostic Applications:

  • lipB-based lateral flow assays for rapid field detection

  • Multiplex PCR systems incorporating lipB-specific primers

  • Development of monoclonal antibodies against unique lipB epitopes for immunodiagnostics

These approaches are particularly important given the emerging global threat status of R. felis, with human infections reported across multiple continents and evidence of R. felis in diverse arthropod vectors beyond fleas .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.